Text Size

Text Messaging for Adherence in Adolescent Liver Transplant Recipients

This study is currently recruiting participants.
Verified September 2012 by Stanford University
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01696331
First received: September 27, 2012
Last updated: September 28, 2012
Last verified: September 2012
History of Changes
  Purpose

Text message reminders will improve adherence to lab tests in adolescent liver transplant recipients.


Condition Intervention
Adherence to Lab Tests
 Behavioral: Text Message Reminder

Study Type: Interventional
Official Title: Impact of Text Messaging on Adherence in Adolescent Liver Transplant Patients

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Adherence to lab tests [ Time Frame: One year ] [ Designated as safety issue: No ]

Study Start Date: September 2012
Estimated Study Completion Date: January 2025
Estimated Primary Completion Date: January 2025 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Text Message Reminder Behavioral: Text Message Reminder

Detailed Description:

Adolescent patients who received a liver transplant will be recruited to participate in receiving text message reminders for lab tests. They will be send de-identified messages according to their required lab schedule. The investigators will monitor their adherence to lab tests as well as medication and clinic visits. They will also have a questionnaire about their medical regimen before and at the end of the study.

  Eligibility

Ages Eligible for Study:   12 Years to 25 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Patient >12 years
  • Received liver transplant
  • Followed by Stanford Liver Transplant Team

Exclusion Criteria:

  • No personal cell phone
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01696331

Contacts
Contact: Rebecca McKenzie 650-723-5070

Locations
United States, California
Lucile Packard Children's Hospital Recruiting
Palo Alto, California, United States, 94304
Contact: Rebecca McKenzie     650-723-5070        
Principal Investigator: Kenneth Cox            
Sponsors and Collaborators
Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01696331     History of Changes
Other Study ID Numbers: 25318
Study First Received: September 27, 2012
Last Updated: September 28, 2012
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on May 16, 2013